Topical ruxolitinib for the treatment of granuloma faciale.

Wong, Alan; Stahly, Samuel; Kieffer, Jason; Dunn, Charles; Nathoo, Rajiv

Wong, Alan; Stahly, Samuel; Kieffer, Jason; Dunn, Charles; Nathoo, Rajiv.

Afiliação

Wong A; Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida.
Stahly S; Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida.
Kieffer J; Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida.
Dunn C; Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida.
Nathoo R; Department of Dermatology, KCU-GME/ADCS Consortium, Maitland, Florida.

JAAD Case Rep ; 36: 73-74, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37250006

Palavras-chave

JAK inhibitor; eosinophil-associated dermatosis; granuloma faciale; interferon-gamma; interleukin-5; janus kinase; pathogenesis; ruxolitinib; topical ruxolitinib; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google